Hyundai Motor Group to Invest $6.26 Billion in AI Data Center, Robotics and Renewable Energy Projects in South Korea 
Wall Street Futures Tumble as U.S.-Iran Conflict Escalates and Oil Prices Surge 
FCC Approves Charter Communications’ $34.5 Billion Acquisition of Cox Communications 
Gold Prices Steady in Asia, Set for Strong February Gains on Safe-Haven Demand 
Oil Prices Surge 13% as U.S.-Israel Strikes on Iran Spark Supply Fears 
APEX Tech Acquisition Inc. Raises $111.97 Million in NYSE IPO Under Ticker TRADU 
Samsung and SK Hynix Shares Hit Record Highs as Nvidia Earnings Boost AI Chip Demand 
Trump Media Weighs Truth Social Spin-Off Amid $6B Fusion Energy Pivot 
Amazon’s $50B OpenAI Investment Tied to AGI Milestone and IPO Plans 
Netflix Stock Jumps 14% After Exiting Warner Bros Deal as Paramount Seals $110 Billion Acquisition 
OpenAI Pentagon AI Contract Adds Safeguards Amid Anthropic Dispute 
Germany and China Reaffirm Open Trade and Strategic Partnership in Landmark Beijing Visit 
FAA Plans Flight Reductions at Chicago O’Hare as Airlines Ramp Up Summer Schedules 
Strait of Hormuz LNG Crisis Triggers Global Energy Market Shock 
Boeing Secures $166.8 Million U.S. Navy Contract for P-8A Engineering and Software Support 
MOEX Russia Index Hits 3-Month High as Energy Stocks Lead Gains 
Coupang Reports Q4 Loss After Data Breach, Revenue Misses Estimates 
Roche will be making big changes in the organization of its employees, which is estimated to be around 100,000 in number. The company is taking this step as it implements new prioritization of the works.
Announcement of change in the workforce
As part of the plans, Roche will be eliminating 300 to 400 jobs this year. The affected employees will be the ones working at the company’s product development sites.
According to Reuters, the news about job cuts was announced by Levi Garraway, the firm’s chief medical officer. Through a video call with the employees, he directly told them what the company is planning to do.
"We have made the difficult decision to reduce our workforce in PD by around five to seven percent by the end of the year," he said. "And that equates to somewhere between 300 to 400 roles that will be impacted globally."
The company knows that this is a big blow to the affected workers, so Roche will try to lessen the impact by working with employees. It was not mentioned, though, how the company intends to help those who are about to lose their position.
Who are set to lose their jobs
Based on the information shared, the Roche employees that will be cut from the company are those who are in the product development units and working in the area of project management, business management, administrative support, project delivery, managers, and posts in learning and development.
The product development sites that will cut workers are located in Canada, Britain, United States, Switzerland, and China. Those who will be laid off are set to be notified between the months of August and October, and British employees are the first ones to go.
Felix Arellano, Roche’s head of global drug safety, admitted that this is the hardest thing that he had to do since he started working for the company. He was referring to the fact that he has to send off colleagues as they have been eliminated by the company, as per Fierce Biotech.
Finally, while Roche is cutting jobs, some of the other major pharmaceutical companies are looking for more workers. Most are building new factories, so they need to hire hundreds of workers.
